Stem-cell therapies for blood diseases

Nature

Volumn 441, Issue 7097, 2006, Pages 1100-1102

  Bordignon, Claudio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; DISEASES; GENE TRANSFER; MEDICAL APPLICATIONS; MEDICAL PROBLEMS; PATIENT TREATMENT;

BLOOD DISEASES; CLINICAL PROTOCOLS; GENE-DELIVERY VECTORS; IMMUNE SYSTEMS; STEM-CELL THERAPIES; THERAPIES; TREATMENT;

CYTOLOGY;

BLOOD SYSTEM DISORDER; DEVELOPING WORLD; IMMUNE SYSTEM; TRANSPLANTATION;

BLOOD DISEASE; CELL BASED GENE THERAPY; CLINICAL PROTOCOL; DNA MODIFICATION; GENE DELIVERY SYSTEM; GENETIC DISORDER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL;

EID: 33745592761     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature04962     Document Type: Short Survey

References (26)

1. Thomas, E. D., Lochte, H. L., Lu, W. C. & Ferrebee, J. W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med 12, 491-496 (1957).
2. Gatti, R. A., Meuwissen, H. J., Allen, H. D., Hong, R. & Good, R. A. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 292, 1366-1369 (1968).
3. Spangrude, G. J., Heimfeld, S. & Weissman, I. L. Purification and characterization of mouse hematopoietic stem cells. Science 241, 58-62 (1988).
4. Thomas, E. D. Bone marrow transplantation - past, present and future (Nobel Lecture, December 8, 1990).
5. Reisner, Y. et al. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61, 341-348 (1983).
6. O'Reilly, R. J., Keever, C. A., Small, T. N. & Brochstein. J. The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodefic. Rev. 1, 273-309 (1989).
7. Corti, P. et al. Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation. Br. J. Haematol. 130, 249-255 (2005).
8. Lucarelli, G., Andreani, M. & Angelucci, E. The cure of thalassemia by bone marrow transplantation. Blood Rev. 16, 81-85 (2002).
9. Boulad, F. et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br. J. Haematol. 111, 1153-1157 (2000).
10. Thomas, E. D., Lochte, H. L., Cannon, J. H., Sahler, O. D. & Ferrebee J. W. Supralethal whole body irradiation and isologous marrow transplantation in man. J. Clin. Invest. 38, 1709-1716 (1959).
11. Aversa, F. et al. Treatment of high risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N. Engl. J. Med. 339, 1186-1193 (1998).
12. Gregori, S., Bacchetta, R., Hauben, E., Battaglia, M. & Roncarolo, M. G. Regulatory T cells: prospective for clinical application in hematopoietic stem cell transplantation. Curr. Opin. Hematol. 12, 451-456 (2005).
13. Bonini, C. et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724 (1997).
14. Bordignon, C. et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270, 470-475 (1995).
15. Cavazzana-Calvo, M. et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 28, 669-672 (2000).
16. Aiuti, A. et al. Correction of ADA-SCID by stem cell gene therapy combined with a non-myeloablative conditioning. Science 296, 2410-2413 (2002).
17. Ott, M. G. et al. Correction of chronic granulomatous disease by gene therapy augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 Nature Med. 12, 401-409 (2006).
18. Sadelain, M. et al. Progress toward the genetic treatment of the β-thalassemias. Ann. NY Acad. Sci. 1054, 78-91 (2005).
19. Hacein-Bey-Abina, S. et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 17, 415-419 (2003).
20. Fischer, A., Abina, S. H., Thrasher, A., Von Kalle, C. & Cavazzana-Calvo, M. LMO2 and gene therapy for severe combined immunodeficiency. N. Engl. J. Med. 350, 2526-2527 (2004).
21. Gaspar, H. B. et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped γretroviral vector. Lancet 364, 2181-2187 (2004).
22. Biffi, A. et al. Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J. Clin. Invest. 113, 1118-1129 (2004).
23. Ferrari, G. et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 6, 1528-1530 (1998).
24. Grompe, M. Bone marrow-derived hepatocytes. Novartis Found. Symp. 265, 20-27 (2005).
25. Nadal-Ginard, B., Anversa, P., Kajstura, J. & Leri, A. Cardiac stem cells and myocardial regeneration. Novartis Found. Symp. 265, 142-154 (2005).
26. De Palma, M., Venneri, M. A., Roca, C. & Naldini, L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nature Med. 9, 789-795 (2003).